AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+10.88%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.61B
AUM Growth
+$1.61B
Cap. Flow
+$49.7M
Cap. Flow %
3.09%
Top 10 Hldgs %
87.2%
Holding
88
New
12
Increased
7
Reduced
4
Closed
9

Sector Composition

1 Consumer Discretionary 55.71%
2 Healthcare 35.03%
3 Financials 1.36%
4 Technology 0.96%
5 Industrials 0.67%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MBLY
26
DELISTED
Mobileye N.V.
MBLY
$5.36M 0.2% +100,000 New +$5.36M
NEOG icon
27
Neogen
NEOG
$1.25B
$4.94M 0.18% 125,000
MRTX
28
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.38M 0.16% 250,000
XOMA icon
29
Xoma
XOMA
$392M
$4.21M 0.15% 1,000,000
RL icon
30
Ralph Lauren
RL
$18B
$4.12M 0.15% 25,000
CPRI icon
31
Capri Holdings
CPRI
$2.45B
$3.57M 0.13% +50,000 New +$3.57M
CFG icon
32
Citizens Financial Group
CFG
$22.6B
$3.51M 0.13% +150,000 New +$3.51M
CERE
33
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$3.36M 0.12% 8,192,167
CSLT
34
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$3.24M 0.12% 250,000
RXDX
35
DELISTED
Ignyta, Inc.
RXDX
$3.02M 0.11% 375,000 +75,000 +25% +$605K
SPHS
36
DELISTED
Sophiris Bio, Inc.
SPHS
$2.93M 0.11% 1,000,000
PARN
37
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$2.88M 0.11% +500,000 New +$2.88M
IRWD icon
38
Ironwood Pharmaceuticals
IRWD
$214M
$2.81M 0.1% 216,879
STML
39
DELISTED
Stemline Therapeutics, Inc.
STML
$2.12M 0.08% 170,000
OUT icon
40
Outfront Media
OUT
$3.12B
$1.95M 0.07% +65,145 New +$1.95M
AGEN
41
Agenus
AGEN
$133M
$1.28M 0.05% 410,130
SFXE
42
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$1.26M 0.05% 250,000
CCXI
43
DELISTED
ChemoCentryx, Inc.
CCXI
$1.24M 0.05% 275,000
AMGN icon
44
Amgen
AMGN
$155B
0
AMRN
45
Amarin Corp
AMRN
$311M
0
AMZN icon
46
Amazon
AMZN
$2.44T
-50,000 Closed -$16.2M
ARMK icon
47
Aramark
ARMK
$10.3B
-200,000 Closed -$5.18M
BAC icon
48
Bank of America
BAC
$376B
-100,000 Closed -$1.54M
BIIB icon
49
Biogen
BIIB
$19.4B
0
BMY icon
50
Bristol-Myers Squibb
BMY
$96B
0